Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2021-02-05
2022-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GEBT Telehealth Administration Usability Study
NCT04684992
Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
NCT07005895
Transcutaneous Bilirubinometry in Neonates With Bilicare System
NCT02372058
ABCA2 GIRMS Analytical Validation Clinical Performance Study
NCT04607304
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
NCT02756234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lot-to-Lot Variability
Participants will be administered up to six different 13C-Spirulina test meal lots
13C-Spirulina GEBT
Various lots of 13C-Spirulina GEBT test meals
Biological Variability
Participants will be administered the same 13C-Spirulina test meal lot on two different occasions
13C-Spirulina GEBT
Various lots of 13C-Spirulina GEBT test meals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
13C-Spirulina GEBT
Various lots of 13C-Spirulina GEBT test meals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to eat test meal and provide breath samples
Exclusion Criteria
* History of abdominal surgery except appendectomy
* Use of any medications that may alter gastric motility within two days of the study
* Use of narcotics or anticholinergics within two days of the study
* Females on hormone replacement therapy other than birth control medications
* Pregnancy
* Intolerance or allergy to any component of GEBT test meal
* History of neurologic or psychiatric disorders
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairn Diagnostics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alex Ryder, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Cairn Diagnostics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairn Diagnostics
Brentwood, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO-CD-050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.